Inventor · disambiguated record
Anna Maria Langkilde
Also filed as: LANGKILDE ANNA MARIA
6 granted patents·3 pending applications·5 citations·filing 2019–2024
72Inventor score
Technology areasA61K
Files withASTRAZENECA AB9
Top patents by PatentIndex Score
9 records- 0191US10973836B2Methods of treating heart failure with reduced ejection fractionASTRAZENECA AB·Filed 2020·Granted Apr 13, 2021·4 cites·30 claims
- 0283US11903955B2Methods of treating heart failure with reduced ejection fractionASTRAZENECA AB·Filed 2021·Granted Feb 20, 2024·1 cites·27 claims
- 0377US2025161339A1Methods of treating chronic kidney disease with dapagliflozinASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0475US2024216404A1Methods of treating heart failure with reduced ejection fractionASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0574US12472194B2Methods of treating heart failure with preserved ejection fraction employing dapagliflozin and compositions comprising the sameASTRAZENECA AB·Filed 2023·Granted Nov 18, 2025·0 cites·33 claims
- 0669US12213988B2Methods of treating chronic kidney disease with dapagliflozinASTRAZENECA AB·Filed 2021·Granted Feb 4, 2025·0 cites·24 claims
- 0768US12409186B2Methods of treating chronic kidney disease with dapagliflozinASTRAZENECA AB·Filed 2021·Granted Sep 9, 2025·0 cites·22 claims
- 0864US11826376B2Methods of treating heart failure with preserved ejection fraction employing dapagliflozin and compositions comprising the sameASTRAZENECA AB·Filed 2019·Granted Nov 28, 2023·0 cites·27 claims
- 0960US2025108065A1Methods of treating prediabetes or reducing the risk of developing type 2 diabetes with dapagliflozinASTRAZENECA AB·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anna Maria Langkilde files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →